Loading...

We are the Peptide Experts


JPT Peptide Technologies is the leading manufacturer of custom peptides and innovative peptide-based products for research and clinical applications. For more than 15 years we have been serving the worldwide biomedical community with science and quality driven products and services.

Located in our state-of-the-art laboratories in Berlin, Germany, JPT operates according to the most recent ISO 9001:2015 regulations.


Custom Peptide Synthesis


Our Quality Guarantee

Since 2004 JPT maintains an active quality management system that is annually reviewed, audited and certified by an independent certifcation body (TÜV Rheinland) to meet ISO 9001 standards. Therefore, we have installed complete process documentation and an early signaling procedure in case of problems.



Product Finder

Search by scientific field

Research Fields

Cell Therapy & Vaccines

Cell Therapy & Vaccines

JPT offers a large portfolio of peptide products and services supporting all development phases of new cell therapies and vaccines. These products range from discovery tools for epitope and target identification, to various peptide formats for immune monitoring and clinical grade peptides to support clinical vaccination and cell therapy trials.  Learn more
Immunology

Immunology

JPT has developed a variety of unique peptide-based products allowing systematic evaluation of cellular and humoral immunity. In addition to peptide formats allowing T-cell and B-cell epitope discovery, antigen-specific T-cell stimulation and immune monitoring our clinical grade products support clinical trials for the development of new immunotherapeutics and vaccines. Learn more
Neo-Epitope Discovery & Therapy

Neo-Epitope Discovery & Therapy

Neo-epitopes are important targets for individualized cancer immunotherapy. JPT’s high-throughput peptide techniques enable access to customized peptide products for neo-epitope prioritization and validation, individualized therapy development and immune monitoring. Learn more
Proteomics

Proteomics

Proteomics is the study of a cell's protein inventory at different times by protein identification and quantification. The application of mass spectrometry and more specifically LC-MS/MS has tremendously facilitated this process. JPT developed proprietary approaches for the provision of quantified custom peptides and ready-to-use products enabling protein biomarker identification and quantitation. Learn more
COVID-19

COVID-19

JPT was the first company responding to the Covid-19 pandemic with the launch of a broad SARS CoV-2 genome spanning portfolio of peptide tools. The ready to use and custom peptide tools include antigen spanning PepMixTM peptide pools and PepStarTM peptide microarrays of SARS-CoV-2 wild type and mutated antigen sequences as well as antigens from other relevant corona viruses.  Learn more
Loading...

News

NOW available: High purity SARS2 Omicron BA.4/BA.5 PepMixes

After the previous launch of our PepMix peptide pools covering SARS-CoV-2 Omicron BA.4/BA.5 Spike antigens, we now add the >70% purified versions to our catalog. Please note that we at JPT analyze and purify each individual peptide in our 70% PepMixes and assure to provide complete coverage of each antigen:

  • PepMix SARS-CoV-2 (Spike / BA.4/BA.5 / Omicron)
  • PepMix SARS-CoV-2 (S-RBD / BA.4/BA.5 / Omicron)

Learn More

October 2022

ESGCT: Our extensive Peptide Ressources for Gene Therapy

Adenoviruses and Adeno-associated viruses can be used as powerful gene delivery vehicles for the development of vaccines and gene therapy to treat conditions for instance cystic fibrosis, immunodeficiencies (X-SCID), and hematological disorders such as haemophilia and thalassemia. These tools facilitate to detect and monitor the anti-vector T and B-cells' immune response. 

Learn More

October 2022

NEW: PepMix  Pools covering Conserved & Saisonal Influenza A & B Antigens

Based on recommendations, we added selected PepMix peptide pools covering antigens for hemagglutinin (HA) of the following Influenza A & B strains:

  • PepMix Influenza A (HA/H3N2/Darwin/2021)
  • PepMix Influenza A (HA/H1N1/Victoria/2019)
  • PepMix Influenza A (HA/H1N1/Wisconsin/2019)
September 2022

Check our list of products, click and go.

Get a quote